AUG 20, 2014 2:15 PM PDT

Identifying transcriptional regulators of human embryonic development via expression variability

Speaker
  • Assistant Professor, Department of Systems & Computational Biology, Assistant Professor, Department of Epidemiology & Population Health, Albert Einstein College of Medicine
    Biography
      Jessica Mar is an Assistant Professor at Albert Einstein College of Medicine in the Department of Systems and Computational Biology in the Bronx, New York. The focus of the Mar lab is to understand how variability in gene expression contributes to the regulation of cellular phenotypes. Around the topic of variability, her work involves applications in single cell genomics, stem cells, genetics and cancer biology. Jessica Mar received her Bachelor of Science degree in Mathematics at the University of Queensland in Brisbane, Australia and First Class Honors in Statistics in 2002. She got her PhD in Biostatistics from Harvard University in 2008. Previously she was a postdoctoral research fellow at the Dana-Farber Cancer Institute in Boston, and a visiting scientist at the European Bioinformatics Institute in the UK. Since July 2016, Dr. Mar holds a joint appointment with the Australian Institute for Bioengineering and Nanotechnology at the University of Queensland, Australia as a Group Leader.

    Abstract

    Understanding how genes coordinate their expression across cells in a growing embryo can provide insights into the transcriptional programs that control development. Intercellular variability of gene expression reflects how consistent expression levels are between cells of the same embryo. An analysis of expression variability can therefore identify which genes are consistently or heterogeneously expressed in a population of cells, and provides a window into regulatory control. Using an analysis of previously published single-cell RNA-seq data set on embryos at collected at different developmental stages, we have identified a putative set of gene expression markers of morulae and blastocyst stages based on changes in intercellular variability. We highlight how genes with extreme levels of variability are enriched for distinct functions and pathways; lowly variable genes operate in maintenance pathways such as protein synthesis, gene expression and cell cycle while highly variable genes tend to be involved in metabolism. Our results suggest that genes with critical and survival roles for the cell are expressed stably while those related to specialized functions are have variable inter-cellular expression. We identified genes with invariant expression across the development stages; such genes fall clearly into three categories of modes corresponding to off, on and highly activated levels of expression. Genes switched on are involved in critical regulatory pathways like EIF2 signaling, protein ubiquitination and mTOR signaling. Genes that are consistently off function in the development of specialized cell types and metabolites. Overall, our analysis suggests new regulators involved in controlling the development of human embryos that would have otherwise been missed using methods that focus on average expression levels and highlight the value in studying expression variability.


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    C.E. CREDITS
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    Loading Comments...
    Show Resources